Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes

Published:2019-08 Issue:8 Volume:29 Page:989-994
ISSN:1092-6429
Container-title:Journal of Laparoendoscopic & Advanced Surgical Techniques
language:en
Short-container-title:Journal of Laparoendoscopic & Advanced Surgical Techniques

Author:

Di Corpo Marco¹,Schlottmann Francisco²,Strassle Paula D.¹³,Nurczyk Kamil¹,Patti Marco G.¹⁴

Affiliation:

1. Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

2. Department of Surgery, Hospital Alemán of Buenos Aires, University of Buenos Aires, Buenos Aires, Argentina.

3. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

4. Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Publisher

Mary Ann Liebert Inc

Subject

Surgery

Link

https://www.liebertpub.com/doi/pdf/10.1089/lap.2019.0350

Reference18 articles.

1. Cancer statistics, 2019

2. The Troublesome Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma

3. Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and Age

4. Trends in esophageal adenocarcinoma incidence and mortality

5. AJCC Cancer Staging Manual

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esophageal cancer patient survival: A retrospective study from a tertiary care hospital in Pakistan;Pakistan Journal of Medical Sciences;2024-03-25

2. Neoadjuvant versus definitive chemoradiation in locally advanced esophageal cancer for patients of advanced age or significant comorbidities;Diseases of the Esophagus;2022-07-29

3. The Efficacy and Safety of PD-1/PD-L1 Immunosuppressive Agents in Advanced Esophageal Cancer: A Meta-Analysis;Advances in Clinical Medicine;2022

4. Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center;Cancers;2021-09-16

5. Underfunding of Esophageal Cancer Research;The Annals of Thoracic Surgery;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3